Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-08-07 Sale | 2024-08-09 4:30 pm | GLYCOMIMETICS INC | GLYC | Invus Public Equities L.P. Invus Public Equities Advisors LLC Siren L.L.C. Invus Global Management LLC DEBBANE RAYMOND 10% Owner | 322,361 | $0.18987 | $61,206 | 6,317,565 (Direct) | View |
| 2024-08-05 Sale | 2024-08-07 4:30 pm | GLYCOMIMETICS INC | GLYC | Invus Public Equities L.P. Invus Public Equities Advisors LLC Siren L.L.C. Invus Global Management LLC DEBBANE RAYMOND 10% Owner | 220,255 | $0.18698 | $41,184 | 6,639,926 (Direct) | View |
| 2024-08-01 Sale | 2024-08-05 4:53 pm | GLYCOMIMETICS INC | GLYC | Invus Public Equities L.P. Invus Public Equities Advisors LLC Siren L.L.C. Invus Global Management LLC DEBBANE RAYMOND 10% Owner | 349,764 | $0.20327 | $71,097 | 6,860,181 (Direct) | View |
| 2024-07-26 Sale | 2024-07-30 5:16 pm | GLYCOMIMETICS INC | GLYC | Invus Public Equities L.P. Invus Public Equities Advisors LLC Siren L.L.C. Invus Global Management LLC DEBBANE RAYMOND 10% Owner | 1,379,119 | $0.2286 | $315,262 | 7,209,945 (Direct) | View |
| 2024-06-20 Purchase | 2024-06-24 4:29 pm | GLYCOMIMETICS INC | GLYC | Rock Edwin Chief Medical Officer | 305,000 | $0.25844 | $78,825 | 680,403 (Direct) | View |
| 2024-06-18 Purchase | 2024-06-20 4:15 pm | GLYCOMIMETICS INC | GLYC | Hahn Brian M. SVP Finance, CFO | 17,500 | $0.2477 | $4,335 | 70,643 (Direct) | View |
| 2023-09-21 Purchase | 2023-09-25 4:21 pm | GLYCOMIMETICS INC | GLYC | Rock Edwin Chief Medical Officer | 65,403 | $1.38 | $90,256 | 375,403 (Direct) | View |
| 2023-05-17 Sale | 2023-05-18 4:27 pm | GLYCOMIMETICS INC | GLYC | Hahn Brian M. SVP Finance, CFO | 3,700 | $1.95 | $7,215 | 53,143 (Direct) | View |
| 2023-05-10 Purchase | 2023-05-11 5:08 pm | GLYCOMIMETICS INC | GLYC | JUNIUS DANIEL M Director | 30,000 | $1.56 | $46,800 | 93,250 (Direct) | View |
| 2023-05-08 Purchase | 2023-05-09 5:00 pm | GLYCOMIMETICS INC | GLYC | Johnson Bruce S SVP & Chief Commercial Officer | 13,500 | $1.57 | $21,195 | 138,980 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2024-07-29 5:55 pm | N/A N/A | GLYCOMIMETICS INC | GLYC | Siren L.L.C. Invus Global Management LLC DEBBANE RAYMOND 10% Owner | 0 | $0 | 8,589,064 (Direct) | View |
| 2024-05-01 Option Award | 2024-05-01 4:30 pm | N/A 2034-04-30 | GLYCOMIMETICS INC | GLYC | Koenig Scott Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2024-05-01 Option Award | 2024-05-01 4:30 pm | N/A 2034-04-30 | GLYCOMIMETICS INC | GLYC | Goldberg Mark Alan Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2024-05-01 Option Award | 2024-05-01 4:29 pm | N/A 2034-04-30 | GLYCOMIMETICS INC | GLYC | PEARSON TIMOTHY R Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2024-05-01 Option Award | 2024-05-01 4:27 pm | N/A 2034-04-30 | GLYCOMIMETICS INC | GLYC | King Rachel K. Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2024-05-01 Option Award | 2024-05-01 4:26 pm | N/A 2034-04-30 | GLYCOMIMETICS INC | GLYC | Andrews Patricia S Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2024-05-01 Option Award | 2024-05-01 4:25 pm | N/A 2034-04-30 | GLYCOMIMETICS INC | GLYC | Jackson Scott Thomas Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2024-05-01 Option Award | 2024-05-01 4:24 pm | N/A 2034-04-30 | GLYCOMIMETICS INC | GLYC | JUNIUS DANIEL M Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2024-03-29 Option Award | 2024-04-02 4:05 pm | N/A N/A | GLYCOMIMETICS INC | GLYC | JUNIUS DANIEL M Director | 5,209 | $3 | 98,459 (Direct) | View |
| 2024-03-29 Option Award | 2024-04-02 4:05 pm | N/A N/A | GLYCOMIMETICS INC | GLYC | King Rachel K. Director | 3,334 | $3 | 659,095 (Direct) | View |
| 2024-03-29 Option Award | 2024-04-02 4:05 pm | N/A N/A | GLYCOMIMETICS INC | GLYC | Goldberg Mark Alan Director | 4,584 | $3 | 36,325 (Direct) | View |
| 2024-01-12 Option Award | 2024-01-17 4:05 pm | N/A 2034-01-11 | GLYCOMIMETICS INC | GLYC | Johnson Bruce S SVP & Chief Commercial Officer | 250,000 | $0 | 250,000 (Direct) | View |
| 2024-01-12 Option Award | 2024-01-17 4:05 pm | N/A 2034-01-11 | GLYCOMIMETICS INC | GLYC | Semerjian Harout Chief Executive Officer | 695,000 | $0 | 695,000 (Direct) | View |
| 2024-01-12 Option Award | 2024-01-17 4:05 pm | N/A 2034-01-11 | GLYCOMIMETICS INC | GLYC | Rock Edwin Chief Medical Officer | 250,000 | $0 | 250,000 (Direct) | View |
| 2024-01-12 Option Award | 2024-01-17 4:05 pm | N/A 2034-01-11 | GLYCOMIMETICS INC | GLYC | Rath Chinmaya SVP and Chief Business Officer | 250,000 | $0 | 250,000 (Direct) | View |
| 2024-01-12 Option Award | 2024-01-17 4:05 pm | N/A 2034-01-11 | GLYCOMIMETICS INC | GLYC | Hahn Brian M. SVP Finance, CFO | 250,000 | $0 | 250,000 (Direct) | View |
| 2023-12-29 Option Award | 2024-01-02 4:05 pm | N/A N/A | GLYCOMIMETICS INC | GLYC | Andrews Patricia S Director | 5,191 | $2.36 | 58,608 (Direct) | View |
| 2023-12-29 Option Award | 2024-01-02 4:05 pm | N/A N/A | GLYCOMIMETICS INC | GLYC | King Rachel K. Director | 4,238 | $2.36 | 657,502 (Direct) | View |
| 2023-12-29 Option Award | 2024-01-02 4:05 pm | N/A N/A | GLYCOMIMETICS INC | GLYC | Goldberg Mark Alan Director | 5,827 | $2.36 | 31,741 (Direct) | View |
| 2023-09-30 Option Award | 2023-10-03 4:15 pm | N/A N/A | GLYCOMIMETICS INC | GLYC | Goldberg Mark Alan Director | 9,167 | $1.5 | 25,914 (Direct) | View |
| 2023-09-30 Option Award | 2023-10-03 4:05 pm | N/A N/A | GLYCOMIMETICS INC | GLYC | Andrews Patricia S Director | 8,167 | $1.5 | 53,417 (Direct) | View |
| 2023-09-30 Option Award | 2023-10-03 4:05 pm | N/A N/A | GLYCOMIMETICS INC | GLYC | King Rachel K. Director | 6,667 | $1.5 | 653,264 (Direct) | View |
| 2023-06-01 Exercise | 2023-06-02 4:10 pm | N/A 2032-05-17 | GLYCOMIMETICS INC | GLYC | Koenig Scott Director | 21,000 | $0 | 36,750 (Direct) | View |
| 2023-06-01 Exercise | 2023-06-02 4:10 pm | N/A N/A | GLYCOMIMETICS INC | GLYC | Koenig Scott Director | 21,000 | $0.6 | 36,750 (Direct) | View |
| 2023-05-19 Option Award | 2023-05-22 4:27 pm | N/A 2033-05-18 | GLYCOMIMETICS INC | GLYC | King Rachel K. Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2023-05-19 Option Award | 2023-05-22 4:25 pm | N/A 2033-05-18 | GLYCOMIMETICS INC | GLYC | JUNIUS DANIEL M Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2023-05-19 Option Award | 2023-05-22 4:24 pm | N/A 2033-05-18 | GLYCOMIMETICS INC | GLYC | Koenig Scott Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2023-05-19 Option Award | 2023-05-22 4:23 pm | N/A 2033-05-18 | GLYCOMIMETICS INC | GLYC | Goldberg Mark Alan Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2023-05-19 Option Award | 2023-05-22 4:21 pm | N/A 2033-05-18 | GLYCOMIMETICS INC | GLYC | PEARSON TIMOTHY R Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2023-05-19 Option Award | 2023-05-22 4:20 pm | N/A 2033-05-18 | GLYCOMIMETICS INC | GLYC | Andrews Patricia S Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2023-05-19 Option Award | 2023-05-22 4:18 pm | N/A 2033-05-18 | GLYCOMIMETICS INC | GLYC | Jackson Scott Thomas Director | 35,000 | $0 | 35,000 (Direct) | View |